Skip to Main Content

Paper Details

Risk-reducing surgery in unaffected individuals receiving cancer genetic testing in an integrated health care system.
Cancer
4
2022
APC, ATM, BRCA1, BRCA2, BRCA2 P/LP variant, BRIP1, CHEK2, Cancer, EPCAM, FLCN, MLH1, MSH2, MSH6, MUTYH, P/LP variants, PALB2, RAD51C, RAD51D, TP53, cancer, hereditary cancer, high-penetrance hereditary cancer susceptibility gene, patients
Author NameAffiliation
Kathleen F MittendorfCenter for Health Research, Kaiser Permanente Northwest
Heather Spencer FeigelsonInstitute for Health Research, Kaiser Permanente
Gail P JarvikUniversity of Washington
Gail P JarvikUniversity of Washington
Tia L KauffmanCenter for Health Research, Kaiser Permanente Northwest
David L VeenstraPolicy and Economics (CHOICE) Institute, School of Pharmacy, University of Washington
Katrina A B GoddardCenter for Health Research, Kaiser Permanente Northwest
  • 1 - 7

Datasets

Release 1.2